https://www.evrysdi-hcp.com/2025-06-16https://www.evrysdi-hcp.com/about-sma/how-sma-affects-the-body.html2025-06-16https://www.evrysdi-hcp.com/about-sma/importance-of-treatment.html2025-06-16https://www.evrysdi-hcp.com/about-evrysdi.html2025-02-11https://www.evrysdi-hcp.com/about-evrysdi/why-evrysdi.html2025-06-16https://www.evrysdi-hcp.com/about-evrysdi/mechanism-of-action.html2025-06-16https://www.evrysdi-hcp.com/efficacy/clinical-trial-program-overview.html2025-06-16https://www.evrysdi-hcp.com/efficacy/results-in-later-onset-sma.html2025-08-11Dr Perry Shieh and Shaniqua explore expectation settingShaniqua, an adult living with Type 3 SMA, conveys her experiences with Evrysdi. Dr Perry Shieh shares his related insights on discussing expectation setting and Evrysdi.https://cf-images.us-east-1.prod.boltdns.net/v1/static/6125588073001/23c988b5-c6c5-49e0-a4b4-73bb789453c0/26283173-df22-4499-bf7a-f2d35d68a98c/231x130/match/image.jpghttps://players.brightcove.net/6125588073001/3cfaAcUC_default/index.html?videoId=6323724835112884 Dr Shadé Moody and Angela discuss treatment considerationsAngela, an adult who lives with Type 2 SMA shares her treatment experience. Neurologist Dr Shadé Moody sheds light on the same considerations from her perspective.https://cf-images.us-east-1.prod.boltdns.net/v1/static/6125588073001/c10d3b3b-3f1a-4222-aced-4cf81619446e/34ef3a86-dce8-4e01-8076-af9a94820081/231x130/match/image.jpghttps://players.brightcove.net/6125588073001/3cfaAcUC_default/index.html?videoId=6322982947112828https://www.evrysdi-hcp.com/efficacy/results-in-infantile-onset-sma.html2025-06-16https://www.evrysdi-hcp.com/efficacy/results-in-presymptomatic-sma.html2025-06-16https://www.evrysdi-hcp.com/efficacy/results-in-previously-treated-sma.html2025-06-16https://www.evrysdi-hcp.com/safety/safety-profile.html2025-05-29https://www.evrysdi-hcp.com/safety/important-safety-information.html2025-02-28https://www.evrysdi-hcp.com/dosing-and-administration/administration-and-storage.html2025-06-17https://www.evrysdi-hcp.com/dosing-and-administration/dosing.html2025-07-08https://www.evrysdi-hcp.com/patient-and-practice-resources/treatment-resources.html2025-06-17https://www.evrysdi-hcp.com/patient-and-practice-resources/resources-for-your-patients.html2025-07-10https://www.evrysdi-hcp.com/patient-and-practice-resources/my-sma-support-program.html2025-03-31https://www.evrysdi-hcp.com/patient-and-practice-resources/access-reimbursement.html2025-03-13https://www.evrysdi-hcp.com/patient-and-practice-resources/practice-forms-and-documents.html2025-02-28https://www.evrysdi-hcp.com/financial-support/assistance-options.html2025-03-18https://www.evrysdi-hcp.com/financial-support/eligibility-and-enrollment.html2025-03-13https://www.evrysdi-hcp.com/financial-support/faqs.html2025-03-13https://www.evrysdi-hcp.com/contact-a-representative.html2025-03-18https://www.evrysdi-hcp.com/site-map.html2025-02-11